Montrose Environmental Group Announces Second Quarter 2022 Results
Montrose Environmental Group (MEG) reported a revenue increase to $139.9 million for Q2 2022, marking a 2.7% growth year-over-year. This rise was driven by organic growth in its Measurement and Analysis and Remediation segments, despite a dip in COVID-19-related services. Operating cash flow improved by $18.1 million over the prior year, and adjusted net income reached $5.4 million, or $0.04 per share. The company maintains its 2022 guidance of $520 million to $570 million in revenue and adjusted EBITDA between $68 million to $73 million, reflecting ongoing strong demand for its services.
- Q2 2022 revenue rose to $139.9 million, up 2.7% year-over-year.
- Operating cash flow increased by $18.1 million compared to the prior year.
- Adjusted net income for Q2 2022 was $5.4 million, or $0.04 per share.
- The company maintains its 2022 revenue outlook of $520 million to $570 million.
- Net loss for Q2 was $(7.8) million, an improvement but still a loss.
- Consolidated Adjusted EBITDA decreased to $15.6 million from $19.8 million year-over-year.
- Significantly lower COVID-19-related services impacted overall revenue.
- Increases Revenue to
- Reiterates Full Year 2022 Outlook -
- Increases Operating Cash Flow by
- Introduces Adjusted Net Income1 and Adjusted Net Income Per Share1 Metrics -
Montrose Chief Executive Officer and Director,
________________________________ |
(1) Consolidated Adjusted EBITDA, Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Share are non-GAAP measures. See the appendix to this release for a discussion of these measures, including how they are calculated and the reasons why we believe they provide useful information to investors, and a reconciliation for historical periods to the most directly comparable GAAP measures. |
Second Quarter 2022 Results
Total revenue in the second quarter of 2022 increased
Net loss was
Adjusted Net Income 1 was
Consolidated Adjusted EBITDA1, under the revised methodology, was
First Six Months 2022 Results
Total revenue in the first six months of 2022 increased
Net loss was
Adjusted Net Income1 was
Consolidated Adjusted EBITDA1 for the six months ended
Operating Cash Flow, Liquidity and Capital Resources
Cash used in operating activities for the first six months ended
As of
Acquisitions
In
Full Year 2022 Outlook
The Company reiterates its full year 2022 outlook. The Company expects revenue to be in the range of
The Company’s 2022 forecast reflects an expectation of organic growth outperformance relative to the Company’s historical average of
The outlook does not include any benefit from future acquisitions that have not yet been completed.
Webcast and Conference Call
The Company will host a webcast and conference call on
About Montrose
Montrose is a leading environmental solutions company focused on supporting commercial and government organizations as they deal with the challenges of today, and prepare for what’s coming tomorrow. With approximately 2,800 employees across over 80 locations around the world, Montrose combines deep local knowledge with an integrated approach to design, engineering, and operations, enabling the Company to respond effectively and efficiently to the unique requirements of each project. From comprehensive air measurement and laboratory services to regulatory compliance, emergency response, permitting, engineering, and remediation, Montrose delivers innovative and practical solutions that keep its clients on top of their immediate needs – and well ahead of the strategic curve. For more information, visit www.montrose-env.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by the use of words such as “intend,” “expect”, and “may”, and other similar expressions that predict or indicate future events or that are not statements of historical matters. Forward-looking statements are based on current information available at the time the statements are made and on management’s reasonable belief or expectations with respect to future events, and are subject to risks and uncertainties, many of which are beyond the Company’s control, that could cause actual performance or results to differ materially from the belief or expectations expressed in or suggested by the forward-looking statements. Further, many of these factors are, and may continue to be, amplified by the COVID-19 pandemic. Additional factors or events that could cause actual results to differ may also emerge from time to time, and it is not possible for the Company to predict all of them. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update any forward-looking statement to reflect future events, developments or otherwise, except as may be required by applicable law. Investors are referred to the Company’s filings with the
|
||||||||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND |
||||||||||||||||
COMPREHENSIVE LOSS |
||||||||||||||||
(In thousands, except per share data) |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
REVENUES |
|
$ |
139,910 |
|
|
$ |
136,224 |
|
|
$ |
274,590 |
|
|
$ |
270,041 |
|
COST OF REVENUES (exclusive of
|
|
|
90,429 |
|
|
|
92,104 |
|
|
|
178,815 |
|
|
|
187,420 |
|
SELLING, GENERAL AND ADMINISTRATIVE
|
|
|
46,456 |
|
|
|
27,366 |
|
|
|
88,263 |
|
|
|
52,366 |
|
FAIR VALUE CHANGES IN BUSINESS
|
|
|
(3,510 |
) |
|
|
12,971 |
|
|
|
(3,531 |
) |
|
|
24,035 |
|
DEPRECIATION AND AMORTIZATION |
|
|
12,280 |
|
|
|
9,878 |
|
|
|
24,424 |
|
|
|
21,674 |
|
LOSS FROM OPERATIONS |
|
|
(5,745 |
) |
|
|
(6,095 |
) |
|
|
(13,381 |
) |
|
|
(15,454 |
) |
OTHER INCOME (EXPENSE) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Other income (expense) |
|
|
343 |
|
|
|
(511 |
) |
|
|
2,804 |
|
|
|
(1,393 |
) |
Interest expense—net |
|
|
(1,518 |
) |
|
|
(6,798 |
) |
|
|
(2,610 |
) |
|
|
(9,486 |
) |
Total other (expense) income—net |
|
|
(1,175 |
) |
|
|
(7,309 |
) |
|
|
194 |
|
|
|
(10,879 |
) |
LOSS BEFORE (EXPENSE) INCOME
|
|
|
(6,920 |
) |
|
|
(13,404 |
) |
|
|
(13,187 |
) |
|
|
(26,333 |
) |
INCOME TAX EXPENSE (BENEFIT) |
|
|
831 |
|
|
|
(256 |
) |
|
|
2,100 |
|
|
|
(254 |
) |
NET LOSS |
|
$ |
(7,751 |
) |
|
$ |
(13,148 |
) |
|
$ |
(15,287 |
) |
|
$ |
(26,079 |
) |
EQUITY ADJUSTMENT FROM FOREIGN
|
|
|
(84 |
) |
|
|
28 |
|
|
|
(3 |
) |
|
|
57 |
|
COMPREHENSIVE LOSS |
|
|
(7,835 |
) |
|
|
(13,120 |
) |
|
|
(15,290 |
) |
|
|
(26,022 |
) |
CONVERTIBLE AND REDEEMABLE
|
|
|
(4,100 |
) |
|
|
(4,100 |
) |
|
|
(8,200 |
) |
|
|
(8,200 |
) |
NET LOSS ATTRIBUTABLE TO
|
|
|
(11,851 |
) |
|
|
(17,248 |
) |
|
|
(23,487 |
) |
|
|
(34,279 |
) |
WEIGHTED AVERAGE COMMON SHARES
|
|
|
29,678 |
|
|
|
26,056 |
|
|
|
29,670 |
|
|
|
25,586 |
|
NET LOSS PER SHARE ATTRIBUTABLE
|
|
$ |
(0.40 |
) |
|
$ |
(0.66 |
) |
|
$ |
(0.79 |
) |
|
$ |
(1.34 |
) |
|
||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION |
||||||||
(In thousands, except share data) |
||||||||
|
|
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
||
CURRENT ASSETS: |
|
|
|
|
|
|
||
Cash and restricted cash |
|
$ |
98,414 |
|
|
$ |
146,741 |
|
Accounts receivable—net |
|
|
87,676 |
|
|
|
98,513 |
|
Contract assets |
|
|
47,740 |
|
|
|
40,139 |
|
Prepaid and other current assets |
|
|
10,406 |
|
|
|
8,465 |
|
Total current assets |
|
|
244,236 |
|
|
|
293,858 |
|
NON-CURRENT ASSETS: |
|
|
|
|
|
|
||
Property and equipment—net |
|
|
34,396 |
|
|
|
31,521 |
|
Operating lease right-of-use asset—net |
|
|
29,466 |
|
|
|
23,532 |
|
Finance lease right-of-use asset—net |
|
|
8,278 |
|
|
|
8,944 |
|
|
|
|
315,626 |
|
|
|
311,944 |
|
Other intangible assets—net |
|
|
150,684 |
|
|
|
160,997 |
|
Other assets |
|
|
5,057 |
|
|
|
2,298 |
|
TOTAL ASSETS |
|
$ |
787,743 |
|
|
$ |
833,094 |
|
LIABILITIES, CONVERTIBLE AND REDEEMABLE SERIES A-2
|
|
|
|
|
|
|
||
CURRENT LIABILITIES: |
|
|
|
|
|
|
||
Accounts payable and other accrued liabilities |
|
|
59,285 |
|
|
|
68,936 |
|
Accrued payroll and benefits |
|
|
18,756 |
|
|
|
25,971 |
|
Business acquisitions contingent consideration, current |
|
|
2,814 |
|
|
|
31,450 |
|
Current portion of operating lease liabilities |
|
|
8,226 |
|
|
|
6,888 |
|
Current portion of finance lease liabilities |
|
|
3,462 |
|
|
|
3,512 |
|
Current portion of long-term debt |
|
|
8,750 |
|
|
|
10,938 |
|
Total current liabilities |
|
|
101,293 |
|
|
|
147,695 |
|
NON-CURRENT LIABILITIES: |
|
|
|
|
|
|
||
Business acquisitions contingent consideration, long-term |
|
|
3,560 |
|
|
|
4,350 |
|
Other non-current liabilities |
|
|
81 |
|
|
|
100 |
|
Deferred tax liabilities—net |
|
|
6,207 |
|
|
|
4,006 |
|
Conversion option |
|
|
24,207 |
|
|
|
23,081 |
|
Operating lease liability—net of current portion |
|
|
21,714 |
|
|
|
16,859 |
|
Finance lease liability—net of current portion |
|
|
5,199 |
|
|
|
5,756 |
|
Long-term debt—net of deferred financing fees |
|
|
157,703 |
|
|
|
161,818 |
|
Total liabilities |
|
|
319,964 |
|
|
|
363,665 |
|
COMMITMENTS AND CONTINGENCIES |
|
|
|
|
|
|
||
CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK |
|
|
|
|
|
|
||
Authorized, issued and outstanding shares: 17,500 at |
|
|
152,928 |
|
|
|
152,928 |
|
STOCKHOLDERS’ EQUITY: |
|
|
|
|
|
|
||
Common stock, |
|
|
— |
|
|
|
— |
|
Additional paid-in capital |
|
|
477,783 |
|
|
|
464,143 |
|
Accumulated deficit |
|
|
(162,965 |
) |
|
|
(147,678 |
) |
Accumulated other comprehensive income |
|
|
33 |
|
|
|
36 |
|
Total stockholders’ equity |
|
|
314,851 |
|
|
|
316,501 |
|
TOTAL LIABILITIES, CONVERTIBLE AND REDEEMABLE SERIES A-2
|
|
$ |
787,743 |
|
|
$ |
833,094 |
|
|
||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
(In thousands) |
||||||||
|
|
Six Months Ended |
|
|||||
|
|
2022 |
|
|
2021 |
|
||
OPERATING ACTIVITIES: |
|
|
|
|
|
|
||
Net loss |
|
$ |
(15,287 |
) |
|
$ |
(26,079 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
||
Provision for bad debt |
|
|
(171 |
) |
|
|
590 |
|
Depreciation and amortization |
|
|
24,424 |
|
|
|
21,674 |
|
Amortization of right-of-use asset |
|
|
4,582 |
|
|
|
4,025 |
|
Stock-based compensation expense |
|
|
21,357 |
|
|
|
4,222 |
|
Fair value changes in financial instruments |
|
|
(2,856 |
) |
|
|
1,120 |
|
Fair value changes in business acquisition contingencies |
|
|
(3,531 |
) |
|
|
24,035 |
|
Deferred income taxes |
|
|
2,100 |
|
|
|
(254 |
) |
Debt extinguishment costs |
|
|
— |
|
|
|
4,052 |
|
Other |
|
|
370 |
|
|
|
(87 |
) |
Changes in operating assets and liabilities—net of acquisitions: |
|
|
|
|
|
|
||
Accounts receivable and contract assets |
|
|
8,248 |
|
|
|
(31,009 |
) |
Prepaid expenses and other current assets |
|
|
(433 |
) |
|
|
1,316 |
|
Accounts payable and other accrued liabilities |
|
|
(10,171 |
) |
|
|
1,788 |
|
Accrued payroll and benefits |
|
|
(7,794 |
) |
|
|
(2,846 |
) |
Payment of contingent consideration |
|
|
(19,457 |
) |
|
|
(15,549 |
) |
Other assets |
|
|
— |
|
|
|
(107 |
) |
Change in operating leases |
|
|
(4,323 |
) |
|
|
(3,937 |
) |
Net cash used in operating activities |
|
|
(2,942 |
) |
|
|
(17,046 |
) |
INVESTING ACTIVITIES: |
|
|
|
|
|
|
||
Purchases of property and equipment |
|
|
(3,501 |
) |
|
|
(2,354 |
) |
Proceeds received from corporate owned insurance |
|
|
277 |
|
|
|
— |
|
Proprietary software development and other software costs |
|
|
(147 |
) |
|
|
(208 |
) |
Purchase price true ups |
|
|
(631 |
) |
|
|
(8,377 |
) |
Cash paid for acquisitions—net of cash acquired |
|
|
(14,328 |
) |
|
|
(14,876 |
) |
Net cash used in investing activities |
|
|
(18,330 |
) |
|
|
(25,815 |
) |
FINANCING ACTIVITIES: |
|
|
|
|
|
|
||
Proceeds from line of credit |
|
|
— |
|
|
|
105,000 |
|
Payments on line of credit |
|
|
— |
|
|
|
(40,000 |
) |
Proceeds from term loans |
|
|
— |
|
|
|
175,000 |
|
Repayment of term loan |
|
|
(6,563 |
) |
|
|
(173,905 |
) |
Payment of contingent consideration |
|
|
(10,722 |
) |
|
|
(9,605 |
) |
Repayment of finance leases |
|
|
(1,911 |
) |
|
|
(1,143 |
) |
Debt issuance costs |
|
|
— |
|
|
|
(2,590 |
) |
Proceeds from issuance of common stock for exercised stock options |
|
|
483 |
|
|
|
3,086 |
|
Dividend payment to the Series A-2 shareholders |
|
|
(8,200 |
) |
|
|
(8,200 |
) |
Payments of deferred offering costs |
|
|
(183 |
) |
|
|
— |
|
Net cash (used in) provided by financing activities |
|
|
(27,096 |
) |
|
|
47,643 |
|
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH |
|
|
(48,368 |
) |
|
|
4,782 |
|
Foreign exchange impact on cash balance |
|
|
41 |
|
|
|
526 |
|
CASH, CASH EQUIVALENTS AND RESTRICTED CASH: |
|
|
|
|
|
|
||
Beginning of year |
|
|
146,741 |
|
|
|
34,881 |
|
End of period |
|
$ |
98,414 |
|
|
$ |
40,189 |
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION: |
|
|
|
|
|
|
||
Cash paid for interest |
|
$ |
3,196 |
|
|
$ |
3,397 |
|
Cash paid for income tax |
|
$ |
699 |
|
|
$ |
305 |
|
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: |
|
|
|
|
|
|
||
Accrued purchases of property and equipment |
|
$ |
1,408 |
|
|
$ |
907 |
|
Property and equipment purchased under finance leases |
|
$ |
1,273 |
|
|
$ |
1,766 |
|
Common stock issued to acquire new businesses |
|
$ |
— |
|
|
$ |
2,746 |
|
Acquisitions unpaid contingent consideration |
|
$ |
6,374 |
|
|
$ |
31,152 |
|
Acquisitions contingent consideration paid in shares |
|
$ |
— |
|
|
$ |
25,000 |
|
Non-GAAP Financial Information
In addition to our results under GAAP, in this release we also present certain other supplemental financial measures of financial performance that are not required by, or presented in accordance with, GAAP, including, Consolidated Adjusted EBITDA, Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Share. We calculate Consolidated Adjusted EBITDA as net income (loss) before interest expense, income tax expense (benefit) and depreciation and amortization, adjusted for the impact of certain other items, including stock-based compensation expense and acquisition-related costs, as set forth in greater detail in the table below. We calculate Adjusted Net Income (Loss) as net income (loss) before amortization of intangible assets, stock-based compensation expense, fair value changes to financial instruments and contingent earnouts, and other gain or losses, as set forth in greater detail in the table below. Adjusted Net Income (Loss) per Share represents Adjusted Net Income (Loss) attributable to stockholders divided by the weighted average number of shares of common stock outstanding during the applicable period.
Consolidated Adjusted EBITDA is one of the primary metrics used by management to evaluate our financial performance and compare it to that of our peers, evaluate the effectiveness of our business strategies, make budgeting and capital allocation decisions and in connection with our executive incentive compensation. Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Share are useful metrics to evaluate ongoing business performance after interest and tax. These measures are also frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe they are helpful in highlighting trends in our operating results because they allow for more consistent comparisons of financial performance between periods by excluding gains and losses that are non-operational in nature or outside the control of management, and, in the case of Consolidated Adjusted EBITDA, by excluding items that may differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments.
These non-GAAP measures do, however, have certain limitations and should not be considered as an alternative to net income (loss), earnings (loss) per share or any other performance measure derived in accordance with GAAP. Our presentation of Consolidated Adjusted EBITDA, Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Share should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items for which we may make adjustments. In addition, Consolidated Adjusted EBITDA, Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Share may not be comparable to similarly titled measures used by other companies in our industry or across different industries, and other companies may not present these or similar measures. Management compensates for these limitations by using these measures as supplemental financial metrics and in conjunction with our results prepared in accordance with GAAP. We encourage investors and others to review our financial information in its entirety, not to rely on any single measure and to view Consolidated Adjusted EBITDA, Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Share in conjunction with the related GAAP measures.
Additionally, we have provided estimates regarding Consolidated Adjusted EBITDA for 2022. These projections account for estimates of revenue, operating margins and corporate and other costs. However, we cannot reconcile our projection of Consolidated Adjusted EBITDA to net income (loss), the most directly comparable GAAP measure, without unreasonable efforts because of the unpredictable or unknown nature of certain significant items excluded from Consolidated Adjusted EBITDA and the resulting difficulty in quantifying the amounts thereof that are necessary to estimate net income (loss) . Specifically, we are unable to estimate for the future impact of certain items, including income tax (expense) benefit, stock-based compensation expense, fair value changes and the accounting for the issuance of the Series A-2 preferred stock. We expect the variability of these items could have a significant impact on our reported GAAP financial results.
In this release we also reference our organic growth. We define organic growth as the change in revenues excluding revenues from acquisitions for the first twelve months following the date of acquisition and excluding revenues from businesses disposed of or discontinued. As a result of the significance of CTEH to Montrose, and the potential annual volatility in CTEH’s revenues due to the emergency response aspect of their business, we also disclose organic growth without the annual organic revenue growth of CTEH. We expect to continue to disclose organic revenue growth with and without CTEH. Management uses organic growth as one of the means by which it assesses our results of operations. Organic growth is not, however, a measure of revenue growth calculated in accordance with
|
||||||||||||||||
Reconciliation of Net Loss to Adjusted Net Income |
||||||||||||||||
(in thousands) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
For the Three Months
|
|
|
For the Six Months
|
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Net loss |
|
$ |
(7,751 |
) |
|
$ |
(13,148 |
) |
|
$ |
(15,287 |
) |
|
$ |
(26,079 |
) |
Amortization of intangible assets(1) |
|
|
9,492 |
|
|
|
8,407 |
|
|
|
18,911 |
|
|
|
17,002 |
|
Stock-based compensation (2) |
|
|
10,932 |
|
|
|
2,417 |
|
|
|
21,357 |
|
|
|
4,222 |
|
Acquisition costs (3) |
|
|
519 |
|
|
|
506 |
|
|
|
986 |
|
|
|
743 |
|
Fair value changes in financial instruments (4) |
|
|
(407 |
) |
|
|
518 |
|
|
|
(2,856 |
) |
|
|
1,120 |
|
Expenses related to financing transactions (5) |
|
|
— |
|
|
|
— |
|
|
|
7 |
|
|
|
50 |
|
Fair value changes in business acquisition contingencies (6) |
|
|
(3,510 |
) |
|
|
12,971 |
|
|
|
(3,531 |
) |
|
|
24,035 |
|
Other losses and expenses (7) |
|
|
1,216 |
|
|
|
157 |
|
|
|
1,483 |
|
|
|
675 |
|
Tax effect of adjustments (8) |
|
|
(5,108 |
) |
|
|
(6,993 |
) |
|
|
(10,180 |
) |
|
|
(13,397 |
) |
Adjusted Net Income |
|
$ |
5,383 |
|
|
$ |
4,835 |
|
|
$ |
10,890 |
|
|
$ |
8,371 |
|
Preferred Dividend Series A-2 |
|
|
(4,100 |
) |
|
|
(4,100 |
) |
|
|
(8,200 |
) |
|
|
(8,200 |
) |
Adjusted Net Income attributable to
|
|
$ |
1,283 |
|
|
$ |
735 |
|
|
$ |
2,690 |
|
|
$ |
171 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net Loss per share attributable to
|
|
$ |
(0.40 |
) |
|
$ |
(0.66 |
) |
|
$ |
(0.79 |
) |
|
$ |
(1.34 |
) |
Adjusted Net Income per share(9) |
|
$ |
0.04 |
|
|
$ |
0.03 |
|
|
$ |
0.09 |
|
|
$ |
0.01 |
|
Diluted Adjusted Net Income per share(10) |
|
$ |
0.03 |
|
|
$ |
0.02 |
|
|
$ |
0.07 |
|
|
$ |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted average common shares outstanding |
|
|
29,678 |
|
|
|
26,056 |
|
|
|
29,670 |
|
|
|
25,586 |
|
Fully diluted shares |
|
|
37,822 |
|
|
|
32,462 |
|
|
|
37,508 |
|
|
|
32,398 |
|
___________________________________ |
(1) Represents amortization of intangible assets. |
(2) Represents non-cash stock-based compensation expenses related to (i) option awards issued to employees, (ii) restricted stock grants issued to directors and selected employees, (iii) and stock appreciation rights grants issued to selected employees. |
(3) Includes financial and tax diligence, consulting, legal, valuation, accounting and travel costs and acquisition-related incentives related to our acquisition activity. |
(4) Amounts relate to the change in fair value of the interest rate swap instrument and the embedded derivative attached to the Series A-2 preferred stock. |
(5) Amounts represent non-capitalizable expenses associated with refinancing and amending our debt facilities. |
(6) Amounts also reflect the difference between the expected settlement value of acquisition related earn-out payments at the time of the closing of acquisitions and the expected (or actual) value of earn-outs at the end of the relevant period. |
(7) In 2022, amounts include costs associated with the closing of a lab. In 2021, amounts include non-operational charges incurred due to the remeasurement of finance leases as a result of the adoption of ASC 842 and costs related to the implementation of a new ERP. |
(8) Applies Montrose's marginal tax rate of |
(9) Represents Adjusted Net Income attributable to stockholders divided by the weighted average common shares outstanding. |
(10) Represents Adjusted Net Income attributable to stockholders divided by fully diluted shares. |
|
||||||||||||||||
Reconciliation of Net Loss to Consolidated Adjusted EBITDA |
||||||||||||||||
(in thousands) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
For the Three Months Ended |
|
|
For the Six Months
|
|
||||||||||
|
|
2022 |
|
|
2021(a) |
|
|
2022 |
|
|
2021(a) |
|
||||
Net loss |
|
$ |
(7,751 |
) |
|
$ |
(13,148 |
) |
|
$ |
(15,287 |
) |
|
$ |
(26,079 |
) |
Interest expense |
|
|
1,518 |
|
|
|
6,798 |
|
|
|
2,610 |
|
|
|
9,486 |
|
Income tax expense (benefit) |
|
|
831 |
|
|
|
(256 |
) |
|
|
2,100 |
|
|
|
(254 |
) |
Depreciation and amortization |
|
|
12,280 |
|
|
|
9,878 |
|
|
|
24,424 |
|
|
|
21,674 |
|
EBITDA |
|
$ |
6,878 |
|
|
$ |
3,272 |
|
|
$ |
13,847 |
|
|
$ |
4,827 |
|
Stock-based compensation (1) |
|
|
10,932 |
|
|
|
2,417 |
|
|
|
21,357 |
|
|
|
4,222 |
|
Acquisition costs (2) |
|
|
519 |
|
|
|
506 |
|
|
|
986 |
|
|
|
743 |
|
Fair value changes in financial instruments (3) |
|
|
(407 |
) |
|
|
518 |
|
|
|
(2,856 |
) |
|
|
1,120 |
|
Expenses related to financing transactions (4) |
|
|
— |
|
|
|
— |
|
|
|
7 |
|
|
|
50 |
|
Fair value changes in business
|
|
|
(3,510 |
) |
|
|
12,971 |
|
|
|
(3,531 |
) |
|
|
24,035 |
|
Other losses and expenses(6) |
|
|
1,216 |
|
|
|
157 |
|
|
|
1,483 |
|
|
|
675 |
|
Consolidated Adjusted EBITDA |
|
$ |
15,628 |
|
|
$ |
19,841 |
|
|
$ |
31,293 |
|
|
$ |
35,672 |
|
___________________________________ |
(a) Prior period amounts have been recalculated from amounts originally disclosed using the current methodology. |
(1) Represents non-cash stock-based compensation expenses related to (i) option awards issued to employees, (ii) restricted stock grants issued to directors and selected employees, (iii) and stock appreciation rights grants issued to selected employees. |
(2) Includes financial and tax diligence, consulting, legal, valuation, accounting and travel costs and acquisition-related incentives related to our acquisition activity. |
(3) Amounts relate to the change in fair value of the interest rate swap instrument and the embedded derivative attached to the Series A-2 preferred stock. |
(4) Amounts represent non-capitalizable expenses associated with refinancing and amending our debt facilities. |
(5) Reflects the difference between the expected settlement value of acquisition related earn-out payments at the time of the closing of acquisitions and the expected (or actual) value of earn-outs at the end of the relevant period. |
(6) In 2022, amounts include costs associated with the closing of a lab. In 2021, amounts include non-operational charges incurred due to the remeasurement of finance leases as a result of the adoption of ASC 842 and costs related to the implementation of a new ERP. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220808005716/en/
Investor Relations:
(949) 988-3383
ir@montrose-env.com
Media Relations:
(646) 361-1427
Montrose@icrinc.com
Source:
FAQ
What was Montrose Environmental Group's revenue for Q2 2022?
What is the adjusted net income for MEG in the second quarter of 2022?
How did Montrose's operating cash flow change in 2022?
What are the 2022 revenue expectations for MEG?